Cowen Inc’s Celgene Corp CELG Stock Holding History

Cowen Inc’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$200K	Sell	422,400 -232,300	-35%	-$22.1M	0.01%	247
2019 Q1	$403K	Buy	+654,700	New	+$57.3M	0.04%	164

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Cowen Inc's CELG Position: Q2 2019 in Review

Cowen Inc increased its Celgene Corp (CELG) stake by 1,509% in Q2 2019, buying an estimated $60.4M and bringing the position to 678,108 shares worth $62.7M. The position accounts for 4.51% of the portfolio, ranked #4.

Cowen Inc first reported a position in CELG in Q1 2015 and has held it in 9 quarters since. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Cowen Inc held 678,108 shares of Celgene Corp worth $62.7M as of Q2 2019.
Cowen Inc bought 635,958 Celgene Corp shares in Q2 2019, an estimated $60.4M.
Celgene Corp made up 4.51% of Cowen Inc's portfolio in Q2 2019, its #4 holding.
Cowen Inc first reported a position in Celgene Corp in Q1 2015 and has held it in 9 quarters since.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.